Moneycontrol
HomeNewsIndiaKaziranga National Park resumes elephant safaris after COVID-19 shutdown
Trending Topics

Kaziranga National Park resumes elephant safaris after COVID-19 shutdown

Forest officials, along with elephant trainers who are known locally as 'mahouts', performed a small ceremony on Sunday before the resumption of the safaris. A local priest, in a Hindu blessing, smeared vermillion on the forehead of the elephants as they prepared to receive their first riders after a long gap.

November 02, 2020 / 19:59 IST
Story continues below Advertisement
Representative image

Elephant safaris have resumed at a famous national park in India's northeastern state of Assam, seven months after being forced to shut by the COVID-19 pandemic.

The Kaziranga National Park, a World Heritage Site, reopened on October 21, part of a wider easing of lockdown restrictions imposed to curb the spread of the virus.

Story continues below Advertisement

From November 1, 37 tourists at a time are allowed to move around the park on the elephants while adhering strictly to COVID-19 safety protocols.

Forest officials, along with elephant trainers who are known locally as 'mahouts', performed a small ceremony on Sunday before the resumption of the safaris.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show